References - iarc

2559. Schlesinger C, Silverberg SG (1999).
Endocervical adenocarcinoma in situ of
tubal type and its relation to atypical tubal
metaplasia. Int J Gynecol Pathol 18: 1-4.
2560. Schmidt-Kittler O, Ragg T, Daskalakis
A, Granzow M, Ahr A, Blankenstein TJ,
Kaufmann M, Diebold J, Arnholdt H, Muller
P, Bischoff J, Harich D, Schlimok G,
Riethmuller G, Eils R, Klein CA (2003). From
latent disseminated cells to overt metastasis:
genetic analysis of systemic breast
cancer progression. Proc Natl Acad Sci
USA 100: 7737-7742.
2561. Schmitt FC, Ribeiro CA, Alvarenga S,
Lopes JM (2000). Primary acinic cell-like
carcinoma of the breast--a variant with
good prognosis? Histopathology 36: 286-
289.
2562. Schmitz MJ, Hendricks DT, Farley J,
Taylor RR, Geradts J, Rose GS, Birrer MJ
(2000). p27 and cyclin D1 abnormalities in
uterine papillary serous carcinoma.
Gynecol Oncol 77: 439-445.
2563. Schmutte C, Marinescu RC, Copeland
NG, Jenkins NA, Overhauser J, Fishel R
(1998). Refined chromosomal localization
of the mismatch repair and hereditary nonpolyposis
colorectal cancer genes hMSH2
and hMSH6. Cancer Res 58: 5023-5026.
2564. Schnarkowski P, Kessler M, Arnholdt
H, Helmberger T (1997). Angiosarcoma of
the breast: mammographic, sonographic,
and pathological findings. Eur J Radiol 24:
54-56.
2 5 6 5 . Schneider A, de Villiers EM,
Schneider V (1987). Multifocal squamous
neoplasia of the female genital tract: significance
of human papillomavirus infection
of the vagina after hysterectomy.
Obstet Gynecol 70: 294-298.
2566. Schneider C, Wight E, Perucchini D,
Haller U, Fink D (2000). Primary carcinoma
of the fallopian tube. A report of 19 cases
with literature review. Eur J Gynaecol
Oncol 21: 578-582.
2567. Schneider JA (1989). Invasive papillary
breast carcinoma: mammographic and
sonographic appearance. Radiology 171:
377-379.
2568. Schneider V, Zimberg ST, Kay S
(1981). The pigmented portio: benign lentigo
of the uterine cervix. Diagn Gynecol
Obstet 3: 269-272.
2569. Schnitt SJ (1997). Morphologic risk
factors for local recurrence in patients
with invasive breast cancer treated with
conservative surgery and radiation therapy.
Breast J. 3: 261-266.
2570. Schnitt SJ, Connolly JL, Recht A,
Silver B, Harris JR (1989). Influence of infiltrating
lobular histology on local tumor
control in breast cancer patients treated
with conservative surgery and radiotherapy.
Cancer 64: 448-454.
2571. Schnitt SJ, Connolly JL, Tavassoli FA,
Fechner RE, Kempson RL, Gelman R, Page
DL (1992). Interobserver reproducibility in
the diagnosis of ductal proliferative breast
lesions using standardized criteria. Am J
Surg Pathol 16: 1133-1143.
2 5 7 2 . Schnuch A (1993). [Post hoc or
propter hoc? On the heuristics of sideeffects
in the example of gynecomastia].
Dtsch Med Wochenschr 118: 796-803.
2 5 7 3 . Schorge JO, Lee KR, Sheets EE
(2000). Prospective management of stage
IA(1) cervical adenocarcinoma by conization
alone to preserve fertility: a preliminary
report. Gynecol Oncol 78: 217-220.
2574. Schorge JO, Miller YB, Qi LJ, Muto
MG, Welch WR, Berkowitz RS, Mok SC
(2000). Genetic alterations of the WT1 gene
in papillary serous carcinoma of the peritoneum.
Gynecol Oncol 76: 369-372.
2575. Schorge JO, Muto MG, Lee SJ,
Huang LW, Welch WR, Bell DA, Keung EZ,
Berkowitz RS, Mok SC (2000). BRCA1-related
papillary serous carcinoma of the peritoneum
has a unique molecular pathogen -
esis. Cancer Res 60: 1361-1364.
2576. Schorge JO, Muto MG, Welch WR,
Bandera CA, Rubin SC, Bell DA, Berkowitz
RS, Mok SC (1998). Molecular evidence for
multifocal papillary serous carcinoma of
the peritoneum in patients with germline
BRCA1 mutations. J Natl Cancer Inst 90:
841-845.
2577. Schottenfeld D, Lilienfeld AM,
Diamond H (1963). Some observations on
the epidemiology of breast cancer among
males. Am J Publ Hlth 53: 890-897.
2578. Schrager CA, Schneider D, Gruener
AC, Tsou HC, Peacocke M (1998). Clinical
and pathological features of breast disease
in Cowden's syndrome: an underrec -
ognized syndrome with an increased risk
of breast cancer. Hum Pathol 29: 47-53.
2579. Schuh ME, Nemoto T, Penetrante RB,
Rosner D, Dao TL (1986). Intraductal carci -
noma. Analysis of presentation, pathologic
findings, and outcome of disease. Arch
Surg 121: 1303-1307.
2580. Schultz DM (1957). A malignant, melonotic
neoplasm of the uterus, resembling
the "retinal anlage" tumours. Arch Pathol
28: 524-532.
2581. Schurch W, Potvin C, Seemayer TA
(1985). Malignant myoepithelioma (myoep -
ithelial carcinoma) of the breast: an ultrastructural
and immunocytochemical study.
Ultrastruct Pathol 8: 1-11.
2582. Schuuring E, Verhoeven E, van
Tinteren H, Peterse JL, Nunnink B,
Thunnissen FB, Devilee P, Cornelisse CJ,
Van de Vijver MJ, Mooi WJ, Michalides
RJAM. (1992). Amplification of genes with -
in the chromosome 11q13 region is indicative
of poor prognosis in patients with
operable breast cancer. Cancer Res 52:
5229-5234.
2583. Schwartz GF, Feig SA, Rosenberg AL,
Patchefsky AS, Schwartz AB (1984).
Staging and treatment of clinically occult
breast cancer. Cancer 53: 1379-1384.
2584. Schwartz GF, Patchefsky AS,
Finklestein SD, Sohn SH, Prestipino A, Feig
SA, Singer JS (1989). Nonpalpable in situ
ductal carcinoma of the breast. Predictors
of multicentricity and microinvasion and
implications for treatment. Arch Surg 124:
29-32.
2585. Schwartz IS, Strauchen JA (1990).
Lymphocytic mastopathy. An autoimmune
disease of the breast? Am J Clin Pathol 93:
725-730.
2586. Schwartz PE (2000). Surgery of germ
cell tumours of the ovary. Forum (Genova)
10: 355-365.
2587. Schwartz PE, Chambers SK,
Chambers JT, Kohorn E, McIntosh S (1992).
Ovarian germ cell malignancies: the Yale
University experience. Gynecol Oncol 45:
26-31.
2588. Schwartz PE, Smith JP (1976).
Treatment of ovarian stromal tumors. Am J
Obstet Gynecol 125: 402-411.
2589. Schweizer P, Moisio AL, Kuismanen
SA, Truninger K, Vierumaki R, Salovaara R,
Arola J, Butzow R, Jiricny J, Peltomaki P,
Nystrom-Lahti M (2001). Lack of MSH2 and
MSH6 characterizes endometrial but not
colon carcinomas in hereditary nonpolyposis
colorectal cancer. Cancer Res 61: 2813-
2815.
2590. Scopsi L, Andreola S, Pilotti S,
Bufalino R, Baldini MT, Testori A, Rilke F
(1994). Mucinous carcinoma of the breast.
A clinicopathologic, histochemical, and
immunocytochemical study with special
reference to neuroendocrine differentiation.
Am J Surg Pathol 18: 702-711.
2591. Scopsi L, Andreola S, Saccozzi R,
Pilotti S, Boracchi P, Rosa P, Conti AR,
Manzari A, Huttner WB, Rilke F (1991).
Argyrophilic carcinoma of the male breast.
A neuroendocrine tumor containing predominantly
chromogranin B (secretogranin
I). Am J Surg Pathol 15: 1063-1071.
2592. Scott SP, Bendix R, Chen P, Clark R,
Dork T, Lavin MF (2002). Missense mutations
but not allelic variants alter the func -
tion of ATM by dominant interference in
patients with breast cancer. Proc Natl
Acad Sci USA 99: 925-930.
2593. Scully R, Anderson SF, Chao DM, Wei
W, Ye L, Young RA, Livingston DM, Parvin
JD (1997). BRCA1 is a component of the
RNA polymerase II holoenzyme. Proc Natl
Acad Sci USA 94: 5605-5610.
2594. Scully R, Chen J, Ochs RL, Keegan K,
Hoekstra M, Feunteun J, Livingston DM
(1997). Dynamic changes of BRCA1 subnu -
clear location and phosphorylation state
are initiated by DNA damage. Cell 90: 425-
435.
2595. Scully R, Chen J, Plug A, Xiao Y,
Weaver D, Feunteun J, Ashley T,
Livingston DM (1997). Association of
BRCA1 with Rad51 in mitotic and meiotic
cells. Cell 88: 265-275.
2596. Scully R, Ganesan S, Brown M, De
Caprio JA, Cannistra SA, Feunteun J,
Schnitt S, Livingston DM (1996). Location of
BRCA1 in human breast and ovarian cancer
cells. Science 272: 123-126.
2597. Scully R, Ganesan S, Vlasakova K,
Chen J, Socolovsky M, Livingston DM
(1999). Genetic analysis of BRCA1 function
in a defined tumor cell line. Mol Cell 4:
1093-1099.
2598. Scully RE (1970). Gonadoblastoma. A
review of 74 cases. Cancer 25: 1340-1356.
2599. Scully RE (1970). Sex cord tumor with
annular tubules a distinctive ovarian tumor
of the Peutz-Jeghers syndrome. Cancer 25:
1107-1121.
2600. Scully RE, Bell DA, Abu-Jawdeh GM
(1995). Update on early ovarian cancer and
cancer developing in benign ovarian
tumors. In: Ovarian Cancer 3, P Mason, F
Sharp, T Blackett, J Berek (eds.),
Chapman and Hall: London, pp. 139-144.
2601. Scully RE, Bonfiglio TA, Kurman RJ,
Silverberg SG, Wilkinson EJ (1994). World
Health Organization: Histological Typing of
Female Tract Tumours. 2nd ed. Springer-
Verlag: Berlin.
2602. Scully RE, Bonfiglio TA, Kurman RJ,
Silverberg SG, Wilkinson EJ (1994). Uterine
corpus. In: World Health Organization:
Histological Typing of Female Genital
Tract Tumors, Springer-Verlag: New York ,
pp. 13-31.
2603. Scully RE, Galdabini JJ, McNeely BU
(1976). Case records of the Massachusetts
General Hospital. Weekly clinicopathological
exercises. Case 14-1976. N Engl J Med
294: 772-777.
2604. Scully RE, Sobin LH (1999). World
Health Organization: Histological Typing of
Ovarian Tumours. 2nd ed. Spinger-Verlag:
Berlin.
2605. Scully RE, Young RH, Clement PB
(1998). Atlas of Tumor Pathology Tumors
of the Ovary, Maldeveloped Gonads,
Fallopian Tube, and Broad Ligament. 3rd
ed. AFIP: Washington,D.C.
2606. Scurry J, Beshay V, Cohen C, Allen D
(1998). Ki67 expression in lichen sclerosus
of vulva in patients with and without associated
squamous cell carcinoma.
Histopathology 32: 399-404.
2607. Scurry J, Brand A, Planner R,
Dowling J, Rode J (1996). Vulvar Merkel
cell tumor with glandular and squamous
differentiation. Gynecol Oncol 62: 292-297.
2608. Scurry J, Craighead P, Duggan M
(2000). Histologic study of patterns of cervical
involvement in FIGO stage II endometrial
carcinoma. Int J Gynecol Cancer 10:
497-502.
2609. Scurry J, Planner R, Grant P (1991).
Unusual variants of vaginal adenosis: a
challenge for diagnosis and treatment.
Gynecol Oncol 41: 172-177.
2610. Scurry JP, Brown RW, Jobling T
(1996). Combined ovarian serous papillary
and hepatoid carcinoma. Gynecol Oncol
63: 138-142.
2611. Sebek BA (1984). Cavernous hemangioma
of the female breast. Cleve Clin Q 51:
471-474.
2612. Seckl MJ, Mulholland PJ, Bishop AE,
Teale JD, Hales CN, Glaser M, Watkins S,
Seckl JR (1999). Hypoglycemia due to an
insulin-secreting small-cell carcinoma of
the cervix. N Engl J Med 341: 733-736.
2613. Secreto G, Zumoff B (1994). Abnormal
production of androgens in women with
breast cancer. Anticancer Res 14: 2113-
2117.
2614. Sedlis A (1961). Primary carcinoma of
the Fallopian tube. Obstet Gynecol Surv 16:
209-226.
2615. Segal GH, Hart WR (1992). Ovarian
serous tumors of low malignant potential
(serous borderline tumors). The relationship
of exophytic surface tumor to peritoneal
"implants". Am J Surg Pathol 16: 577-
583.
2616. Segawa T, Sasagawa T, Yamazaki H,
Sakaike J, Ishikawa H, Inoue M (1999).
Fragile histidine triad transcription abnormalities
and human papillomavirus E6-E7
mRNA expression in the development of
cervical carcinoma. Cancer 85: 2001-2010.
2617. Seidman JD (1994). Mucinous lesions
of the fallopian tube. A report of seven
cases. Am J Surg Pathol 18: 1205-1212.
2618. Seidman JD (1996). Prognostic
importance of hyperplasia and atypia in
endometriosis. Int J Gynecol Pathol 15: 1-9.
2619. Seidman JD (1996). Unclassified
ovarian gonadal stromal tumors. A clinicopathologic
study of 32 cases. Am J Surg
Pathol 20: 699-706.
2620. Seidman JD, Abbondanzo SL,
Bratthauer GL (1995). Lipid cell (steroid
cell) tumor of the ovary: immunophenotype
with analysis of potential pitfall due to
endogenous biotin-like activity. Int J
Gynecol Pathol 14: 331-338.
2621. Seidman JD, Ashton M, Lefkowitz M
(1996). Atypical apocrine adenosis of the
breast: a clinicopathologic study of 37
patients with 8.7-year follow-up. Cancer
77: 2529-2537.
References 413